Christian RECHER
IUCT · University Hospital, Toulouse · +33 5 31 15 63 55
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christian RECHER as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:00 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04150393 · Safety and Tolerability Evaluation of MaaT033MaaT Pharma · completed · Hematologic Diseases, Chemotherapy Effect · principal investigator
- Ph3NCT03765541 · Dexamethasone in Refractory or First Relapsed Acute Myeloid LeukemiaUniversity Hospital, Toulouse · terminated · Relapsed or Refractory Acute Myeloid Leukemia · study director
- Ph2NCT03609060 · Dexamethasone Added to Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML)French Innovative Leukemia Organisation · unknown · Acute Myeloid Leukemia · principal investigator
- N/ANCT03284593 · Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life ConditionUniversity Hospital, Toulouse · active not recruiting · Acute Myeloid Leukemia · principal investigator
- N/ANCT02602587 · Study of Dendrogenin A / Oxysterols Balance Between Healthy Volunteers and Acute Myeloid Leukemia PatientsUniversity Hospital, Toulouse · completed · Acute Myeloid Leukemia · principal investigator
- Ph3NCT00140595 · ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1Lymphoma Study Association · completed · Diffuse Large-Cell Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:00 UTC. The ranking covers the 200 most relevant of 78 PubMed records, and a shared surname and initials can bring in a namesake. All 78 on PubMed
- Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.N Engl J Med · 20191,106 citationsRCR 41.3
- 1,005 citationsRCR 29.4
- Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia.N Engl J Med · 2022463 citationsRCR 30.4
- Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study.Lancet Haematol · 2016377 citationsRCR 10.6
- High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.N Engl J Med · 2007366 citationsRCR 9.4
- 332 citationsRCR 8.7
- 317 citationsRCR 8.4
- 295 citationsRCR 7.1
- 281 citationsRCR 14.8
- Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM).J Clin Oncol · 2021263 citationsRCR 13.3